Inventor · disambiguated record
Thomas Alan Crowell
Also filed as: CROWELL THOMAS A · CROWELL THOMAS ALAN
29 granted patents·277 citations·filing 1982–2004
97Inventor score
Files withLILLY CO ELI29
Top patents by PatentIndex Score
29 records- 0191US6265581B1Selective β3 adrenergic agonistsLILLY CO ELI·Filed 2000·Granted Jul 24, 2001·23 cites·2 claims
- 0282US5786356ASelective β3 adrenergic agonistsLILLY CO ELI·Filed 1997·Granted Jul 28, 1998·38 cites·20 claims
- 0381US5808080ASelective β3 adrenergic agonistsLILLY CO ELI·Filed 1997·Granted Sep 15, 1998·45 cites·5 claims
- 0479US6147115AAntitumor compositions and methods of treatmentLILLY CO ELI·Filed 1993·Granted Nov 14, 2000·14 cites·9 claims
- 0576US5684033ANon-peptide tachykinin receptor antagonistsLILLY CO ELI·Filed 1995·Granted Nov 4, 1997·30 cites·9 claims
- 0675US5670499ANon-peptide tachykinin receptor antagonistsLILLY CO ELI·Filed 1995·Granted Sep 23, 1997·28 cites·9 claims
- 0774US6869957B1Non-peptide tachykinin receptor antagonistsLILLY CO ELI·Filed 2003·Granted Mar 22, 2005·6 cites·20 claims
- 0869US5840738ASelective β-3 adrenergic agonistsLILLY CO ELI·Filed 1997·Granted Nov 24, 1998·10 cites·17 claims
- 0968US6812244B2Naphthyl compounds, intermediates, compositions, and methods of useLILLY CO ELI·Filed 2003·Granted Nov 2, 2004·2 cites·6 claims
- 1067US6413991B1Selective β3 adrenergic agonistsLILLY CO ELI·Filed 2000·Granted Jul 2, 2002·2 cites·30 claims
- 1167US6140352ACarbazolyl-substituted ethanolamines as selective β-3 agonistsLILLY CO ELI·Filed 1997·Granted Oct 31, 2000·18 cites·41 claims
- 1266US7105541B2Naphthyl compounds, intermediates, compositions, and methods of useLILLY CO ELI·Filed 2004·Granted Sep 12, 2006·1 cites·6 claims
- 1363US6046227ASelective β3 adrenergic agonistsLILLY CO ELI·Filed 1998·Granted Apr 4, 2000·8 cites·23 claims
- 1462US5958916ADihydronaphthalene and naphthalene compounds, intermediates, formulations, and methodsLILLY CO ELI·Filed 1997·Granted Sep 28, 1999·15 cites·9 claims
- 1553US6686372B2Selective β3 adrenergic agonistsLILLY CO ELI·Filed 2002·Granted Feb 3, 2004·0 cites·17 claims
- 1650US6727255B1Piperidinyl and piperazinyl tachykinin receptor antagonistsLILLY CO ELI·Filed 1995·Granted Apr 27, 2004·6 cites·9 claims
- 1749US6403577B1Hexamethyleneiminyl tachykinin receptor antagonistsLILLY CO ELI·Filed 1993·Granted Jun 11, 2002·5 cites·9 claims
- 1848US6593345B1Naphthyl compounds, intermediates, compositions, and methods of useLILLY CO ELI·Filed 1997·Granted Jul 15, 2003·5 cites·15 claims
- 1947US6599920B2Naphthalene compounds, intermediates, formulations, and methodsLILLY CO ELI·Filed 1997·Granted Jul 29, 2003·3 cites·17 claims
- 2047US6075040ASelective β3 adrenergic agonistsLILLY CO ELI·Filed 1997·Granted Jun 13, 2000·2 cites·16 claims
- 2147US6020513ADihydronaphthalene and naphthalene compounds, intermediates, formulations, and methodsLILLY CO ELI·Filed 1998·Granted Feb 1, 2000·5 cites·7 claims
- 2246US6093735ASelective β-3 adrenergic agonistsLILLY CO ELI·Filed 1999·Granted Jul 25, 2000·4 cites·17 claims
- 2340US6617347B1Selective β3 adrenergic agonistsLILLY CO ELI·Filed 1999·Granted Sep 9, 2003·1 cites·2 claims
- 2438US5958917ABenzofluorene compounds, intermediates, compositions, and methodsLILLY CO ELI·Filed 1997·Granted Sep 28, 1999·2 cites·11 claims
- 2538US5792762ADihydrobenzofluorene compounds, intermediates, compositions and methodsLILLY CO ELI·Filed 1997·Granted Aug 11, 1998·2 cites·17 claims
- 2637US6060492ASelective β3 adrenergic agonistsLILLY CO ELI·Filed 1997·Granted May 9, 2000·1 cites·22 claims
- 2735US4424362AProcess for preparing a trans-6-propenyl benzimidazoleLILLY CO ELI·Filed 1982·Granted Jan 3, 1984·0 cites·3 claims
- 2834US6232337B1Selective β3 adrenergic agonistsLILLY CO ELI·Filed 1998·Granted May 15, 2001·1 cites·16 claims
- 2932US5939443ASelective β3 adrenergic agonistsLILLY CO ELI·Filed 1997·Granted Aug 17, 1999·0 cites·20 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →